CX3CL1 and myeloid sarcoma: A recent immunohistochemical study of MS- and normal brain tissue demonstrates a constituent CX3CL1 expression in astrocytes and an increased expression in human adult astrocyte cultures stimulated with pro-inflammatory cytokines, but fail to demonstrate an upregulation of CX3CL1 in MS patients [47].